Advertisement
Advertisement

AVNS

AVNS logo

Avanos Medical, Inc.

13.85
USD
Sponsored
+0.05
+0.37%
Mar 26, 15:59 UTC -4
Closed
exchange

After-Market

13.86

+0.01
+0.06%

AVNS Earnings Reports

Positive Surprise Ratio

AVNS beat 30 of 41 last estimates.

73%

Next Report

Date of Next Report
May 04, 2026
Estimate for Q1 26 (Revenue/ EPS)
$173.40M
/
$0.14
Implied change from Q4 25 (Revenue/ EPS)
-4.15%
/
-50.00%
Implied change from Q1 25 (Revenue/ EPS)
+3.52%
/
-46.15%

Avanos Medical, Inc. earnings per share and revenue

On Feb 24, 2026, AVNS reported earnings of 0.28 USD per share (EPS) for Q4 25, beating the estimate of 0.25 USD, resulting in a 14.62% surprise. Revenue reached 180.90 million, compared to an expected 178.19 million, with a 1.52% difference. The market reacted with a -10.44% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 3 analysts forecast an EPS of 0.14 USD, with revenue projected to reach 173.40 million USD, implying an decrease of -50.00% EPS, and decrease of -4.15% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
ClearPoint Neuro, Inc. Common Stock
Report Date
Mar 17, 2026 For Q4 25
Estimate
-$0.20
Actual
-$0.26
Surprise
-27.45%
logo
EDAP TMS SA
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.13
Actual
-$0.21
Surprise
-65.56%
logo
Hyperfine, Inc. Class A Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.05
Surprise
+38.73%
logo
Neuronetics, Inc. Common Stock
Report Date
Mar 17, 2026 For Q4 25
Estimate
-$0.10
Actual
-$0.10
Surprise
+8.09%
logo
InspireMD, Inc.
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.14
Surprise
+29.01%
logo
DarioHealth Corp. Common Stock
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$3.30
Actual
-$3.43
Surprise
-3.71%
logo
Spectral AI, Inc. Class A Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.12
Actual
-$0.11
Surprise
+14.86%
logo
SiNtx Technologies, Inc. Common Stock
Report Date
Mar 20, 2026 For Q4 25
Estimate
-$0.56
Actual
-$0.56
Surprise
-1.60%
logo
Tenon Medical, Inc. Common Stock
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.36
Actual
-$0.38
Surprise
-3.49%
FAQ
For Q4 2025, Avanos Medical, Inc. reported EPS of $0.28, beating estimates by 14.62%, and revenue of $180.90M, 1.52% above expectations.
The stock price moved down -10.44%, changed from $15.23 before the earnings release to $13.64 the day after.
The next earning report is scheduled for May 04, 2026.
Based on 3 analysts, Avanos Medical, Inc. is expected to report EPS of $0.14 and revenue of $173.40M for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement